Hepatitis
B Top News Articles |
|
|
 CDC
Researchers Release Latest Hepatitis A, B, and C Statistics
6-23-2009
|
 Many
People with Chronic Hepatitis B and C Do Not
Receive Appropriate Treatment
6-16-2009
|
High
HBV DNA Level Is the Strongest Predictor of Elevated ALT
6-9-2009
|
Should
Entecavir (Baraclude) and Tenofovir
(Viread) Be First-line Treatment for Chronic Hepatitis B?
6-5-2009 |
Slides
and Posters on Entecavir (Baraclude) and Hepatitis
B Liver Disease Progression Presented at DDW 2009
6-5-2009 |
 Factors
Associated with Development of Hepatocellular Carcinoma
in Chronic Hepatitis B Patients
6-2-2009
|
Does
HBV Viral Load Level Predict Development
of Liver Fibrosis?
5-29-2009
|
 Study
Suggests Genetic Factors May Help Explain
High Rates of Hepatitis B among Asians
5/22/09 |
Researchers
Present Data on Investigational Cyclophilin Inhibitors Debio
025 and SCY-635
5/15/09
|
Telbivudine
(Tyzeka) Continues to Produce Good Results for Chronic Hepatitis B
Patients after 3 Years
5/08/09
|
Tenofovir
(Viread) Is Similarly Effective in Chronic Hepatitis B Patients Regardless
of Liver Cirrhosis Status
5/08/09
|
Addition
of Emtricitabine (Emtriva) Does Not Improve
Response to Tenofovir (Viread) for Chronic
Hepatitis B
5/05/09
|
Half
of HBeAg Negative Chronic Hepatitis B Patients Maintain Response up to 5 Years
after Stopping Long-term Adefovir (Hepsera)
5/05/09
|
Chronic
Hepatitis B Patients Who Had Incomplete Response or Relapse on Adefovir
(Hepsera) Respond Well to Entecavir (Baraclude)
5/01/09
|
Safety
and Efficacy of 96 Weeks of Tenofovir (Viread)
in Chronic Hepatitis B Patients Previously Treated with Lamivudine
(Epivir-HBV)
4/28/09
|
 Pharmasset
Halts Clinical Trials of Clevudine for Chronic
Hepatitis B Due to Safety Concerns, Will Focus on Hepatitis C Pipeline
4/24/09
|
 Studies
of Hepatitis B and C Virus Interaction Produce
Conflicting Results
4/17/09 |
 Some
Individuals Harbor HBV with Adefovir (Hepsera) and Tenofovir
(Viread) Resistance Mutations before They Ever Receive Treatment
4/17/09 |
 Pegylated
Interferon Monotherapy for Treatment of Chronic Hepatitis B
4/07/09 |
ImQuest
Identifies First Non-nucleoside Inhibitors
of Hepatitis B Virus
4/07/09 |
 Meta-analysis
Shows Interferon Reduces Progression to Cirrhosis and
Liver Cancer in People with Chronic Hepatitis B
4/03/09 |
Chronic
Hepatitis B Patients May Need to Begin Liver Cancer Screening
at a Younger Age than Currently Recommended
3/27/09 |
 Two
Year Tenofovir Disoproxil Fumarate (TDF) Treatment and
Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Positive Patients With
Chronic Hepatitis B (Study 103)
3/27/09 |
 Variables
Impacting Treatment and Prognosis in Young Patients (under Age 40) who Develop
Hepatitis B Virus-Associated Hepatocellular Carcinoma;
Implications for Management of an Unscreened Population
3/27/09 |
Two
Year Tenofovir Disoproxil Fumarate (TDF) Treatment and
Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Negative Patients with
Chronic Hepatitis B (Study 102)
3/27/09 |
Tenofovir
Disoproxil Fumarate (TDF) versus Adefovir Dipivoxil (ADV) in Asians
with HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B Participating in Studies
102 and 103
3/27/09 |
Many
Asian-American Primary Care Providers Do Not Screen their Asian-American Patients
Who Are at Risk for Chronic Hepatitis B
3/24/09 |
Tenofovir
(Viread) during Pregnancy: Findings from the Antiretroviral Pregnancy
Registry
3/24/09 |
Frequent
Liver Function Tests Can Detect Transient ALT Increases in Chronic
Hepatitis B Patients
3/20/09 |
Entecavir (Baraclude)
Produces Greater Early HBV DNA Suppression than Adefovir (Hepsera) in Chronic
Hepatitis B Patients
3/17/09 |
Telbivudine
(Tyzeka) May Be Effective for Chronic Hepatitis B Treatment after Failure
of Adefovir (Hepsera)
3/10/09 |
 GLOBE
Trial 2-Year Data Shows Telbivudine (Tyzeka)
Is More Effective than Lamivudine (Epivir-HBV)
for Chronic Hepatitis B
2/27/2009 |
 HBV Relapse
after 48 Weeks of Entecavir (Baraclude) Suggests
Need for Continuous Therapy
2/24/2009 |
 Hepatitis
Delta Increases the Risk of Liver Cirrhosis and Hepatocellular Carcinoma in People
with Hepatitis B
2/24/2009 |
 Does Telbivudine (Tyzeka)
Have Activity Against HIV?
2/17/2009 |
Despite
Infrequent "Blips," Tenofovir (Viread) Provides
Good Hepatitis B Virus Suppression HIV-HBV Coinfected Individuals
2/17/2009 |
 Japanese Study Finds Entecavir
(Baraclude) Is Effective and Well-tolerated in Treatment-naive Chronic
Hepatitis B Patients
2/10/2009 |
 Monday Is Deadline to Apply for Association of Asian
Pacific Community Health Organizations Hepatitis B
Policy Fellowship
2/06/2009 |
European
Association for the Study of the Liver (EASL) Publishes First
Guidelines for Management of Chronic Hepatitis B
2/03/2009 |
Japanese
Study Finds Entecavir (Baraclude) Is Effective
and Well-tolerated in Treatment-naive Chronic Hepatitis B Patients
2/03/2009 |
 Insulin
Resistance in Chronic Hepatitis B Patients Is Associated with Other
Metabolic Abnormalities, Not HBV Infection Itself
1/30/2009 |
CDC
Finds Failure to Follow Proper Infection-control Procedures
Put More than 60,000 People at Risk for Hepatitis B
and C over the Past Decade
1/30/2009
|
 Adefovir (Hepsera)
Prevents Post-transplant HBV Recurrence as well as HBIG
1/27/2009 |
 Final
Statement from Consensus Development Conference
on Management of Hepatitis B
1/13/2009 |
Liver
Cirrhosis Is Common in HBeAg Negative Chronic Hepatitis B Patients,
especially Those with High ALT and HBV DNA Levels
1/23/2009
|
 Organizers
Announce 13th International Symposium on Viral Hepatitis
and Liver Disease, March 20-24 in Washington, DC
1/23/2009
|
Higher
Dose of Adefovir (Hepsera) Are Not Effective
for Chronic Hepatitis B Patients with Lamivudine (Epivir) Resistance
1/09/2009 |
Significance
of HBV DNA Levels in People with HBeAg Negative
Chronic Hepatitis B
1/05/2009 |
 Perinatal
HBV Transmission and Management of Pregnant Women with Hepatitis
B
12/12/2008
|
 Do
HBeAg Negative Chronic Hepatitis B Patients with Low HBV Viral Load Require Liver
Biopsy?
12/08/2008
|
 Tenofovir
(Viread) versus Adefovir (Hepsera) for the Treatment of Chronic Hepatitis B
12/05/2008 |
Baseline
CD4 Cell Count Predicts HBV DNA Decline in HIV Negative and HIV Positive Patients
Treated with Adefovir (Hepsera)
12/05/2008
|
Hepatitis
B Virus Genotype Influences HBV Viral Load and Liver Fibrosis Progression
12/02/2008
|
Simvastatin
(Zocor) Is Active against Wild-type and Drug-Resistant Hepatitis B
Virus 11/21/2008 |
Rescue
Therapy with Entecavir (Baraclude) plus Tenofovir (Viread)
Is Safe and Effective for Cirrhotic Hepatitis B Patients with Prior Treatment
Failures
11/21/2008 |
Adding
Ribavirin Does Not Improve Response to Pegylated Interferon for Chronic
Hepatitis B
11/14/2008 |
Tenofovir
(Viread) Produces Continued HBV Suppression through 96 Weeks in HBeAg
Positive and Negative Patients: Studies 102 and 103
11/07/2008 |
Long-term
Entecavir (Baraclude) Reverses Liver Fibrosis
in HBeAg Positive and HBeAg Negative Chronic Hepatitis B Patients
11/04/2008 |
 Hepatitis
B Virus Reverse Transcriptase Drug Resistance Mutations Lead to Treatment
Failure
10/31/2008
|
 Antiviral
Therapy May Promote Hepatitis B Virus Genotype
Changes
10/24/2008 |
 Hepatitis
B Persistence after HBsAg Clearance Is Associated with Increased Risk of Hepatocellular
Carcinoma
10/21/2008 |
 Does
Hepatitis B Vaccination Raise the Risk of
Multiple Sclerosis?
10/10/08 |
 Exposure
to Hepatitis B Virus May Increase the Risk of Pancreas
Cancer
10/07/08 |
 Long-term
Efficacy and Safety of Adefovir (Hepsera)
for the Treatment of Chronic Hepatitis B in HBeAg Positive Patients
10/03/08 |
 Sustained
HBeAg and HBsAg Loss in Chronic Hepatitis B Patients Treated
with Pegylated Interferon
9/25/08 |
 CDC
Issues New Guidelines for Hepatitis B Testing and Management
9/23/08 |
High
Pre-treatment ALT Levels May Predict Earlier HBeAg Seroconversion in Chronic Hepatitis
B Patients Treated with Lamivudine (Epivir-HBV)
9/16/08 |
 FDA
Approves First Hepatitis B Viral Load Test
9/09/2008 |
FDA
Warns of Potential Problems with Certain Prescription Drugs
9/09/2008 |
HBV
Reactivation Leads to a High Risk of Fulminant Liver
Failure and Death
9/05/08 |
Prior
Non-responders Respond Well to a Double Dose of Combined Hepatitis
A and B Vaccine - 8/29/2008 |
Experimental
Nasal Hepatitis B Vaccine Produces Immune
Response with a Single Dose in Animal Study - 8/29/2008 |
Tenofovir
(Viread) Effective against Entecavir-resistant Hepatitis
B Virus - 8/26/2008 |
Anticoagulant
Drug Warfarin May Slow Liver Fibrosis Progression
- 8/26/2008
|
FDA
Approves Gilead's Tenofovir (Viread) for Treatment of Chronic Hepatitis
B - 8/15/08 |
Liver
Cell Dysplasia Predicts Development of Hepatocellular
Carcinoma in Patients with Chronic Hepatitis B
- 8/01/08 |
Virological
and Histological Features and Predictors of Fibrosis
in Hepatitis B Patients with Persistently Normal ALT -7/29/08 |
HBV
and Hepatocellular Carcinoma Recurrence after Resection Surgery and
Liver Transplantation -
7/25/08 |
Tailored
Interferon Therapy Based on Individual Response
Produces Superior Results in Chronic Hepatitis B Patients -
7/22/08 |
| Prevalence
of Fibrosis and Cirrhosis in Patients with
Chronic Hepatitis B -
7/15/08 |
 Pharmasset
Announces New Trial to Study Clevudine plus Tenofovir
(Viread) for Chronic Hepatitis B -
7/11/08 |
FDA
Revises Process for Responding to Drug Approval Applications
from Pharmaceutical Companies -
7/11/08 |
UK
Health Agency Recommends Approval of Entecavir (Baraclude)
for Treatment of Eligible Patients with Chronic Hepatitis B -
6/24/08 |
Resistance
to Adefovir (Hepsera) and Lamivudine (Epivir-HBV)
in Chronic Hepatitis B Patients -
6/24/08 |
Adolescents
May Require Hepatitis B Vaccine Boosters
- 6/20/08
|
Association
between ALT and HBV DNA Viral Load in Chronic Hepatitis B Patients Treated with
Pegylated Interferon -
6/16/08 |
Association
between Hepatitis B and C Virus Infection
and Extrahepatic Bile Duct Cancer -
6/16/08 |
Safety,
Efficacy, and Pharmacokinetics of Adefovir (Hepsera)
in Children and Adolescents with Chronic Hepatitis B
- 6/13/08
|
Combination
Therapy with Lamivudine (Epivir-HBV) plus
Adefovir (Hepsera) for Chronic
Hepatitis B Prevents Resistance to Both Drugs -
6/10/08 |
Higher
HBV DNA Levels Linked to Increased Risk of Liver Cirrhosis
in People with Chronic Hepatitis B - 6/10/08 |
Chronic
Hepatitis B Patients with Normal or Minimally Elevated ALT and Detectable
HBV DNA May Experience Active Liver Disease Progression
- 6/06/08
|
Pegylated
Interferon Alfa-2a (Pegasys) Continues to
Suppress HBV, but Adding Adefovir (Hepsera)
Provides No Extra Benefit in PEG for B Trial
- 6/03/08
|
 High
Maternal HBV Viral Load, but Not HBeAg Status, Predicts Mother-to-child Hepatitis
B Transmission - 5/30/08 |
FDA
Proposes New Rule to Provide Updated Information on Use of Prescription Drugs
and Biological Products during Pregnancy and Breast-feeding - 5/30/08 |
Response
to Pegylated Interferon in Adolescents with
Chronic Hepatitis B - 5/23/08 |
HCV
May Inhibit HBV Replication in HCV-HBV Coinfected
Patients
|
Tenofovir
(Viread) Demonstrates Good Efficacy and Tolerability
in Hepatitis B Patients with Compensated Liver Cirrhosis
- 5/13/08
|
Tenofovir
May Be More Effective and Less Expensive than Lamivudine (Epivir-HBV)
and Adefovir (Hepsera) as First-line Treatment
for HBeAg- Chronic Hepatitis B - 5/09/08 |
Lamivudine
(Epivir-HBV) plus Adefovir (Hepsera)
Is an Effective Regimen for Lamivudine-resistant HBV Patients Who Develop Resistance
to Entecavir (Baraclude) - 5/09/08 |
Pegylated
Interferon plus Ribavirin Is Effective for Patients with HCV-HBV
Coinfection -
5/09/08 |
Entecavir
(Baraclude) Produces Greater Decrease in HBV
DNA than Adefovir (Hepsera) in Treatment-naive
HBeAg+ Patients: 96 Week Data from EARLY Study
- 5/06/08
|
Three
Years of Continuous Entecavir (Baraclude)
in Chinese Patients with Prior Lamivudine (Epivir-HBV)
Failure: Studies ETV-056 and ETV-050 -
5/06/08 |
Entecavir
(Baraclude) Treatment in Japanese Nucleoside-naive
Chronic Hepatitis B Patients -
5/06/08 |
R.E.V.E.A.L.-HBV
Study Shows Persistently High Hepatitis B Viral Load Raises the Risk
of Liver Cancer -
4/29/08 |
